Breakthrough medicines unlocking the biology of heme
Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.
What they do:
Adventris makes cancer vaccines
Quick facts:
HQ: Baltimore, MD, United States
What they do:
Building programmable therapeutics for the immune system
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Targeting the Tumor Ecosystem to address cancer drug resistance.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Dendritic cell-based platform for cancer therapy
Quick facts:
HQ: Boston, MA, United States
What they do:
Our drugs engage the immune system to fight tumors
Quick facts:
HQ: Salt Lake City, UT, United States
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
Breakthrough medicines unlocking the biology of heme
San Francisco, CA, United States
5 employees, according to the company profile.
There are no funding rounds for Velorum Therapeutics in our data.
Similar startups: Adventris Pharmaceuticals, Granza Bio, and Alixia.